Overview and Scope
Chromatin immunoprecipitation (ChIP) sequencing is a powerful molecular biology technique used to study the interactions between proteins and DNA within a cell. It provides insights into the binding patterns of specific proteins (often transcription factors or other chromatin-associated proteins) to the DNA in a genome-wide manner.
Sizing and Forecast
The chip sequencing market size has grown rapidly in recent years. It will grow from $12.36 billion in 2023 to $13.89 billion in 2024 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to understanding gene regulation, rise in epigenetics studies, data analysis and bioinformatics tools, cost reduction and scalability..
The chip sequencing market size is expected to see rapid growth in the next few years. It will grow to $22.26 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to industry investment and competition, clinical adoption and diagnostic applications, demand for biomarker discovery, rapid development in bioinformatics tools, expanded applications in drug discovery.. Major trends in the forecast period include clinical translation and diagnostic applications, focus on histone modifications, application in novel research areas, advancements in sample preparation, multi-omics integration..
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/chromatin-immunoprecipitation-chip-sequencing-global-market-report
Segmentation & Regional Insights
The chromatin immunoprecipitation (chip) sequencing market covered in this report is segmented –
1) By Type: DNase-Sequencing, FAIRE-Sequencing
2) By Technology: Targeted Sequencing And Re-Sequencing, Whole Genome Sequencing And Whole Exome Sequencing
3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis
4) By Application: Consumables And Reagents, Service, Other Applications
5) By End-User: Academic Research Institutes, Clinical Research Institutes, Hospitals And Clinics, Pharmaceuticals And Biotechnology Companies, Other End Users
North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13265&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of prostate cancer is expected to propel the growth of the chromatin immunoprecipitation (ChIP) sequencing market going forward. Prostate cancer is a type of cancer that develops in the prostate gland, a walnut-sized gland in men that produces fluid that helps semen. In prostate cancer research, ChIP-seq offers a comprehensive view of the molecular events driving the disease, providing critical information that can lead to a better understanding of its biology and the development of more targeted and effective therapeutic interventions. For instance, in January 2023, according to the American Cancer Society, a US-based cancer-fighting organization, in the US it is estimated that there were 288,300 new cases of prostate cancer and 34,700 deaths from prostate cancer in 2023. Therefore, the increasing prevalence of prostate cancer is driving the growth of the chromatin immunoprecipitation (ChIP) sequencing market.
Key Industry Players
Major companies operating in the chromatin immunoprecipitation (chip) sequencing market report are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc. , PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Porvair Sciences Ltd. , Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.
The chromatin immunoprecipitation (chip) sequencing market report table of contents includes:
1. Executive Summary
2. Chromatin Immunoprecipitation (ChIP) Sequencing Market Characteristics
3. Chromatin Immunoprecipitation (ChIP) Sequencing Market Trends And Strategies
4. Chromatin Immunoprecipitation (ChIP) Sequencing Market – Macro Economic Scenario
5. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Size and Growth
.
.
.
32. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Benchmarking
33. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Chromatin Immunoprecipitation (ChIP) Sequencing Market
35. Chromatin Immunoprecipitation (ChIP) Sequencing Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
